Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Biol ; 31(15): 3409-3418.e6, 2021 08 09.
Article in English | MEDLINE | ID: mdl-34111402

ABSTRACT

Epithelial tissues are highly sensitive to anisotropies in mechanical force, with cells altering fundamental behaviors, such as cell adhesion, migration, and cell division.1-5 It is well known that, in the later stages of carcinoma (epithelial cancer), the presence of tumors alters the mechanical properties of a host tissue and that these changes contribute to disease progression.6-9 However, in the earliest stages of carcinoma, when a clonal cluster of oncogene-expressing cells first establishes in the epithelium, the extent to which mechanical changes alter cell behavior in the tissue as a whole remains unclear. This is despite knowledge that many common oncogenes, such as oncogenic Ras, alter cell stiffness and contractility.10-13 Here, we investigate how mechanical changes at the cellular level of an oncogenic cluster can translate into the generation of anisotropic strain across an epithelium, altering cell behavior in neighboring host tissue. We generated clusters of oncogene-expressing cells within otherwise normal in vivo epithelium, using Xenopus laevis embryos. We find that cells in kRasV12, but not cMYC, clusters have increased contractility, which introduces radial stress in the tissue and deforms surrounding host cells. The strain imposed by kRasV12 clusters leads to increased cell division and altered division orientation in neighboring host tissue, effects that can be rescued by reducing actomyosin contractility specifically in the kRasV12 cells. Our findings indicate that some oncogenes can alter the mechanical and proliferative properties of host tissue from the earliest stages of cancer development, changes that have the potential to contribute to tumorigenesis.


Subject(s)
Cell Division , Neoplasms , Oncogenes , Proto-Oncogene Proteins p21(ras) , Animals , Anisotropy , Carcinogenesis/genetics , Neoplasms/genetics , Proto-Oncogene Proteins p21(ras)/genetics , Xenopus laevis
2.
J Cell Sci ; 131(16)2018 08 28.
Article in English | MEDLINE | ID: mdl-30154086

ABSTRACT

Dynamic Cell III, a meeting jointly organized by the British Society of Cell Biology (BSCB) and the Biochemical Society, took place at the Manchester Conference Centre, Manchester, UK in March 2018. It brought together a diverse group of scientists from around the world, all with a shared interest in understanding how dynamic functions of the cell are fulfilled. A particular focus was the regulation of the cytoskeleton: in cell division, cell migration and cell-cell interactions. Moreover, a key theme that ran through all presented work was the development of new and exciting technologies to study dynamic cell behaviour.


Subject(s)
Cell Biology/trends , Cell Physiological Phenomena , Congresses as Topic , Cell Biology/organization & administration , Cell Communication , Cell Division/physiology , Cell Movement , Computational Biology/trends , Cytoskeleton/metabolism , Extracellular Matrix/physiology , Humans , Inventions , Molecular Imaging/methods , Molecular Imaging/trends , Proteomics/trends , Single-Cell Analysis/methods , Single-Cell Analysis/trends
3.
Cancer Res ; 76(12): 3520-30, 2016 06 15.
Article in English | MEDLINE | ID: mdl-27197167

ABSTRACT

Basal subtype breast cancers have a particularly poor prognosis, with high invasiveness and resistance to most targeted therapies. TGFß and MYC drive central features of basal breast cancer: TGFß is an autocrine and paracrine signaling factor that drives cell invasion and metastasis, and MYC is a central regulator of cellular proliferation that is upregulated in many cancer types. We show here that genetic or pharmacologic inhibition of MYC in MCF10A basal breast cells results in increased sensitivity to TGFß-stimulated invasion and metastasis and also show that this signaling loop is dependent on activation of SRC. Analysis of human breast cancer datasets and additional experiments with breast cancer cell lines further suggest the relevance of this signaling loop in basal, but not luminal, breast cancers. Our results imply precaution should be taken when utilizing therapeutic inhibitors of MYC with basal breast cancer patients as this could lead to increased metastasis; however, simultaneous pharmacologic inhibition of SRC and MYC for these patients could facilitate the antiproliferative effects of MYC inhibition while blocking the consequent promotion of metastasis. Cancer Res; 76(12); 3520-30. ©2016 AACR.


Subject(s)
Breast Neoplasms/pathology , Proto-Oncogene Proteins c-myc/physiology , Transforming Growth Factor beta/pharmacology , Cell Line, Tumor , Female , Humans , Integrin alphaVbeta3/physiology , Neoplasm Invasiveness , Neoplasm Metastasis , Proto-Oncogene Proteins c-myc/antagonists & inhibitors , src-Family Kinases/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...